Releases dopamine + norepinephrine via TAAR1 activation and reversal of DAT/NET vesicular transporters. Pure d-isomer is more CNS-selective (vs racemic MAS); narrower peripheral sympathetic profile than l-amphetamine.
Half-Life & Elimination Curve (PO: 10h)
Plasma (PO)t½ Decay (10h)
0×t½0h100%(60.1 µg/L)
1×t½10h50%(30 µg/L)
2×t½20h25%(15 µg/L)
3×t½30h12.5%(7.51 µg/L)
4×t½40h6.3%(3.76 µg/L)
5×t½50h3.1%(1.88 µg/L)
Elimination t½10h (PO)
Rate Constant (ke)0.0693 h⁻¹
Time to Peak (Tmax)2.52h
Est. Peak (Cmax)60.1 µg/L
Clearance (CL)14.6 L/h
97% Washout (5×t½)50h
Dosing Guidelines
Oral (PO): Typical 16.7 mg (Range: 5–40 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 90% · Volume of Distribution (Vd): 210 L · Absorption (ka): 1.2 h⁻¹ (t½ka ≈ 35m) [PMID 28936175]